Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland | Zendy

Maria HemmingHarlo | Zendy; Timo Vesikari | Zendy; Matti Uhari | Zendy; Marjo Renko | Zendy; Marjo Salminen | Zendy; Laurence TorcelPag | Zendy; Susanne Hartwig | Zendy; François Simondon | Zendy; Hélène Bricout | Zendy

Open Access

Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland

Author(s) -

Maria HemmingHarlo,

Timo Vesikari,

Matti Uhari,

Marjo Renko,

Marjo Salminen,

Laurence TorcelPag,

Susanne Hartwig,

François Simondon,

Hélène Bricout

Publication year - 2016

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piw061

Subject(s) - medicine , rotavirus vaccine , rotavirus , pediatrics , acute gastroenteritis , rotavirus gastroenteritis , confidence interval , vaccination , immunization , immunization program , virology , diarrhea , immunology , antibody

The effectiveness of pentavalent rotavirus vaccine against rotavirus-associated hospitalization was more than 90% 4 years after introduction into the national immunization program in Finland. A major impact on hospitalization for all-cause gastroenteritis was observed also.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research